Skip to main content
OPKO HEALTH, INC. logo

OPKO HEALTH, INC. — Investor Relations & Filings

Ticker · OPK US Manufacturing
Filings indexed 2,254 across all filing types
Latest filing 2026-05-15 Proxy Solicitation & In…
Country US United States of America
Listing US OPK

About OPKO HEALTH, INC.

https://www.opko.com/

OPKO Health, Inc. is a diversified healthcare company operating in two primary segments: diagnostics and pharmaceuticals. The diagnostics division includes BioReference Laboratories, one of the largest full-service clinical laboratories in the United States, offering a wide range of testing services. The pharmaceuticals division focuses on developing and commercializing novel therapies for serious diseases. Key products include NGENLA™, a long-acting human growth hormone for pediatric patients, and RAYALDEE® for secondary hyperparathyroidism in adults with chronic kidney disease. The company's research is centered on advancing multispecific therapies for conditions such as cancers and infectious diseases, often through strategic partnerships with other leading global organizations.

Recent filings

Filing Released Lang Actions
DEFA14A
Proxy Solicitation & Information Statement
2026-05-15 English
4 - OPKO HEALTH, INC. (0000944809) (Issuer)
Director's Dealing
2026-03-20 English
4 - OPKO HEALTH, INC. (0000944809) (Issuer)
Director's Dealing
2026-03-20 English
3 - OPKO HEALTH, INC. (0000944809) (Issuer)
Director's Dealing
2026-03-20 English
8-K - OPKO HEALTH, INC. (0000944809) (Filer)
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated March 18, 2026, reporting the appointment of a new director to the company's Board of Directors. The content focuses on the departure and appointment of directors, detailing the new director's background and compensation arrangements. There is no financial data or report attached, and the primary subject is a change in board membership. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). Therefore, this document is best classified as MANG.
2026-03-19 English
10-K - OPKO HEALTH, INC. (0000944809) (Filer)
Annual Report FY 2025
2026-02-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.